The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses

Ottawa Heart Institute Research Corporation76 enrolled

Overview

The purpose of this prospective randomized controlled trial is to explore the role of a motion sensor with accompany web application on step counts, energy balance, and metabolic markers in nurses. Additionally, eating behaviours, behavioural regulation in exercise, and mood states that may impact these parameters will also be examined.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Cardiovascular Risk Factor Cardiovascular Diseases

Interventions

Motion sensorBEHAVIORAL

To explore the role of a motion sensor with accompanying web application on step counts, energy balance, and metabolic markers in nurses

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 1\. Participant must be a registered nurse with the University of Ottawa Heart Institute; 2\. Participant must be 18 years of age or older; 3\. Participant must be able to walk unassisted; 4\. Participant is able and willing to provide informed consent. Exclusion Criteria: 1. Participant is pregnant, lactating or planning to become pregnant during the study period; 2. Participant is unable to read and understand English; 3. Medical contraindications to exercise; 4. Already using a motion sensor device to track physical activity. -

Locations (1)

University of Ottawa Heart Institute

Ottawa, Ontario, Canada

Outcomes

Primary Outcomes

Step counts

All participants will be asked to wear a Tractivity® motion sensor device on their ankle for to assess their daily step count and physical activity energy expenditure

Time frame: 6 weeks during observation and 6 weeks during intervention

Secondary Outcomes

Body Mass (kg)

Body weight will be measured using a digital scale to the nearest 0.1 kilogram

Time frame: Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

Waist Circumference

Waist circumference will be measured using a tape measure

Time frame: Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

Fat mass

Fat mass will be measured using bioelectrical impedance analysis

Time frame: Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.